Bank of New York Mellon Corp Cuts Stock Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

Bank of New York Mellon Corp cut its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 2.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,478,343 shares of the company's stock after selling 37,779 shares during the period. Bank of New York Mellon Corp owned approximately 0.60% of Church & Dwight worth $162,751,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. IAG Wealth Partners LLC increased its position in shares of Church & Dwight by 92.9% in the first quarter. IAG Wealth Partners LLC now owns 270 shares of the company's stock valued at $30,000 after buying an additional 130 shares in the last quarter. Bernard Wealth Management Corp. purchased a new stake in Church & Dwight in the 4th quarter worth $40,000. Wayfinding Financial LLC acquired a new position in Church & Dwight during the first quarter worth $40,000. Versant Capital Management Inc raised its position in Church & Dwight by 42.1% during the first quarter. Versant Capital Management Inc now owns 378 shares of the company's stock worth $42,000 after acquiring an additional 112 shares during the period. Finally, Banque Transatlantique SA purchased a new position in Church & Dwight during the fourth quarter valued at $46,000. Hedge funds and other institutional investors own 86.60% of the company's stock.

Insider Activity at Church & Dwight

In other news, Director Ravichandra Krishnamu Saligram sold 14,660 shares of the company's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $99.00, for a total value of $1,451,340.00. Following the transaction, the director directly owned 13,747 shares in the company, valued at approximately $1,360,953. This represents a 51.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Richard A. Dierker bought 7,950 shares of the business's stock in a transaction on Tuesday, May 13th. The stock was purchased at an average cost of $94.66 per share, for a total transaction of $752,547.00. Following the transaction, the chief executive officer owned 16,358 shares of the company's stock, valued at $1,548,448.28. This trade represents a 94.55% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold a total of 50,575 shares of company stock valued at $4,910,586 over the last quarter. 2.00% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Oppenheimer reduced their price target on shares of Church & Dwight from $120.00 to $115.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Truist Financial set a $110.00 target price on Church & Dwight and gave the company a "buy" rating in a report on Friday, June 6th. TD Cowen lowered Church & Dwight from a "buy" rating to a "hold" rating and set a $100.00 price target on the stock. in a research note on Tuesday, May 6th. Wells Fargo & Company boosted their price target on Church & Dwight from $105.00 to $108.00 and gave the stock an "overweight" rating in a research report on Wednesday. Finally, Wall Street Zen upgraded Church & Dwight from a "sell" rating to a "hold" rating in a report on Saturday, June 21st. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $107.43.

Church & Dwight Trading Up 0.4%

NYSE:CHD traded up $0.41 on Wednesday, hitting $98.45. The stock had a trading volume of 2,472,606 shares, compared to its average volume of 1,766,366. The company has a fifty day moving average price of $96.43 and a two-hundred day moving average price of $102.68. Church & Dwight Co., Inc. has a 1-year low of $90.99 and a 1-year high of $116.46. The company has a quick ratio of 1.43, a current ratio of 1.95 and a debt-to-equity ratio of 0.48. The stock has a market cap of $24.25 billion, a price-to-earnings ratio of 42.25, a PEG ratio of 3.93 and a beta of 0.51.

Church & Dwight (NYSE:CHD - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.02. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.52 billion. Church & Dwight had a return on equity of 19.28% and a net margin of 9.52%. The firm's revenue for the quarter was down 2.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.96 earnings per share. Equities research analysts expect that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Thursday, May 15th were paid a dividend of $0.295 per share. This represents a $1.18 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend was Thursday, May 15th. Church & Dwight's dividend payout ratio (DPR) is presently 50.64%.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.